Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Novosanis brings Colli-Pee UAS FV-5040 with CE mark to the market offering a solution for oncology screening

16/12/2022
Novosanis has received a CE-mark for their Colli-Pee ® with special preservative solution for oncology research applications.
Read more

Latest blogpost

View all blogs

cost of self-sampling using the Colli-Pee™ device

Assessing the theoretical cost of self-sampling using the Colli-Pee™ device for HPV screening in the U.K.

3/08/2023
Article by: Sanna Abbasi, PhD Evaluating cost is a critical factor in implementing changes in any national healthcare system. In their recent publication , Dr. Susie Huntington from Aquarius Population Health Limited (London, U.K.) and colleagues from the University of Manchester conducted a major...
Read more

Upcoming event

There are no events associated with this category.